Loading
institutionsInstitution
Chao Family Comprehensive Cancer Center, UC Irvine
Orange County's NCI comprehensive cancer centre, pairing UCI Health clinical care with the Beckman Laser Institute's optical imaging science.
Also called: UCI Chao Family CCC
Overview
NCI-designated since 1994, the Chao Family Comprehensive Cancer Center is the only NCI comprehensive centre in Orange County. Its distinctive research asset is UCI's Beckman Laser Institute, a birthplace of biomedical optics and optical imaging of tissue, alongside programmes in cancer systems biology, GI and head and neck cancers, and haematologic malignancies. UCI Health opened a new Irvine medical campus in the mid-2020s, expanding cancer care alongside the Orange hospital. Patients can access NCI cooperative group and investigator-initiated trials.
Location
Orange, CA, US
Type
cancer center · University of California, Irvine
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
comprehensive
OnCo score
#171 · 31 points (0 Newsweek + 15 NCI + 16 from 8 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to University of California, Irvine, including child institutions. 754 works · 12,847 citations · 70% open access · 10% clinical trials · 2% reviews.
Oncology works per year
1702022
1542023
1442024
1592025
1272026
Most works
- Alexandre Chan41 works
- Misako Nagasaka28 works
- Farshid Dayyani22 works
- Jason A. Zell20 works
- Sai‐Hong Ignatius Ou18 works
- Christopher J. Halbrook13 works
- Ding Quan Ng13 works
- Susan O’Brien11 works
- Jennifer Brooke Valerin11 works
- Raymond J. Chan11 works
Most cited
- Optical imaging (Beckman Laser Institute)
- GI oncology
- Head and neck cancer
Krishnansu S. Tewari
Gynaecologic oncologist, Chao Family Comprehensive Cancer Center, UC Irvine
Cervical cancerAnti-angiogenic therapyImmunotherapy
California gynaecologic oncologist who led GOG 240, the trial that made bevacizumab the first targeted drug to lengthen survival in advanced cervical cancer, and EMPOWER-Cervical 1, which did the same for the PD-1 antibody cemiplimab.
Richard Van Etten
Director, Chao Family Comprehensive Cancer Center, University of California, Irvine
Haematological malignanciesLeukaemia biologyCancer centre leadership
Physician-scientist who directs the Chao Family Comprehensive Cancer Center at UC Irvine, the NCI-designated comprehensive cancer centre for Orange County.
Similar pages
- IdeaReal-time margin assessment and image-guided surgery as the global standard
Shares Optical & fluorescence imaging, Fluorescence-guided surgery, Head and neck squamous cell carcinoma.
- TrialGleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Shares Optical & fluorescence imaging, Fluorescence-guided surgery.
- IdeaA pragmatic trial network for intraoperative margin tools, paid on margin reduction
Shares Optical & fluorescence imaging, Fluorescence-guided surgery, Head and neck squamous cell carcinoma.
- CompanyVergent Bioscience
Shares Optical & fluorescence imaging, Fluorescence-guided surgery.
- TechnologyQuantum-dot and molecular ultrasound imaging agents
Shares Optical & fluorescence imaging, Fluorescence-guided surgery.
- Treatment5-Aminolevulinic acid (oral, for glioma surgery)
Shares Optical & fluorescence imaging, Fluorescence-guided surgery.
- CompanyLumicell
Shares Optical & fluorescence imaging, Fluorescence-guided surgery.
- CompanyOn Target Laboratories
Shares Optical & fluorescence imaging, Fluorescence-guided surgery.